Medical News

RSS

SEIU president supports Hillary Clinton’s investment plan to improve lives of home care providers

Today, SEIU President Mary Kay Henry released the following statement in support of Hillary Clinton’s plan to address the care economy vital for America’s seniors and people with disabilities.

25 Nov 2015

AF Association survey shows impact of AF diagnosis on patients

Atrial Fibrillation (AF) Aware Week aims to raise awareness of an important, yet not well understood heart rhythm disturbance. Taking place from the 23-29 November AF Aware Week increases awareness and understanding of AF amongst the general public. With AF effecting over a million people in the UK it is important that understanding of this condition is improved.

25 Nov 2015

Vitamin D supplements have no effect on frequency and severity of colds in asthma patients

Vitamin D supplements do not reduce the number or severity of colds in asthma patients, according to a new study published online ahead of print publication in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

25 Nov 2015

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.

25 Nov 2015

Novartis announces EC approval of Cosentyx for treatment of ankylosing spondylitis, psoriatic arthritis

Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.

25 Nov 2015

Health insurance coverage for transgender people is cost-effective, study finds

A new analysis led by the Johns Hopkins Bloomberg School of Public Health suggests that while most U.S. health insurance plans deny benefits to transgender men and women for medical care necessary to transition to the opposite sex, paying for sex reassignment surgery and hormones is actually cost-effective.

25 Nov 2015

Fat cells produced from bone marrow may be linked to chronic diseases

Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease and some cancers.

25 Nov 2015

Women with moderate-to-severe PMS at increased risk of developing high blood pressure in later life

In the first prospective study to consider premenstrual syndrome (PMS) as a possible sentinel for future risk of hypertension, epidemiologist Elizabeth Bertone-Johnson and colleagues in the School of Public Health and Health Sciences at the University of Massachusetts Amherst and the Harvard School of Public Health report that women with moderate-to-severe PMS had a 40 percent higher risk of developing high blood pressure over the following 20 years compared to women experiencing few menstrual symptoms.

25 Nov 2015

First seasonal influenza vaccine containing adjuvant now approved by FDA

The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older.

25 Nov 2015

Breast Center of Acadiana to deploy Sectra Breast Imaging PACS in two freestanding imaging centers

International medical imaging IT company Sectra announces that Breast Center of Acadiana has entered into a multi-year agreement to deploy Breast Imaging PACS in its two freestanding imaging centers. This investment will provide the Breast Center a future-proof platform capable of expanding with the practice.

24 Nov 2015

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.

24 Nov 2015

New collaboration aims to develop novel generation artificial pancreas

Debiotech SA, the ARTORG Center for Biomedical Engineering Research of the University of Bern - and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital "Inselspital" are proud to announce the start of an exclusive collaboration to develop a novel generation artificial pancreas.

24 Nov 2015

Researchers reveal causal association between aneuploidy and cancer

Publication in Nature Cell Biology: researchers at the Université libre de Bruxelles - ULB Cancer Research Center, U-CRC - show the causal link between aneuploidy and cancer.

24 Nov 2015

xG Health Solutions introduces revolutionary care management platform

xG Health Solutions, a leading healthcare management and redesign company, is pleased to announce the launch of xGCare, a care management platform that helps healthcare organizations improve quality of care, enhance the patient experience and reduce overall costs.

24 Nov 2015

Molecular Dynamics to present revolutionary whole body CZT digital SPECT/CT solution at RSNA meeting

Molecular Dynamics will present its revolutionary whole body CZT digital SPECT/CT solution at the upcoming 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America taking place in Chicago on Nov-29th through Dec-4th, in Booth 1122, Hall A.

24 Nov 2015

T1DM therapeutics market expected to reach $7.1 billion by 2021

Analysis from business intelligence provider GBI Research - Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - states that the global market value for T1DM treatment will rise from $4.2 billion in 2014 to $7.1 billion by 2021, at a robust Compound Annual Growth Rate (CAGR) of 7.9%.

24 Nov 2015

Teledyne DALSA's CMOS X-Ray detector for mammography to be introduced at RSNA 2015 Technical Exhibition

Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will introduce its CMOS X-Ray detector for mammography at the RSNA 2015 Technical Exhibition, November 29 to December 3, at McCormick Place in Chicago.

24 Nov 2015

Impax releases generic version of dutasteride capsules, 0.5 mg

Impax Laboratories, Inc. today announced that on November 20, the Company's development and manufacturing partner received final approval by the U.S. Food and Drug Administration for a generic version of dutasteride capsules, 0.5 mg.

24 Nov 2015

Catasys to provide assistance to Humana members experiencing substance abuse challenges

Catasys, Inc., a provider of proprietary big-data based analytics and predictive modeling driven health management services for health plans, announced today that it has signed a national agreement with Humana Behavioral Health to combine its substance abuse care management with Humana clinical programs to address the needs of members experiencing substance abuse challenges.

24 Nov 2015

Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

Mylan N.V. today announced the U.S. launch of Clozapine Orally Disintegrating Tablets, 25 mg and 100 mg, the generic version of Jazz Pharmaceutical's FazaClo.

24 Nov 2015

Medical News

SEIU president supports Hillary Clinton’s investment plan to improve lives of home care providers

AF Association survey shows impact of AF diagnosis on patients

Vitamin D supplements have no effect on frequency and severity of colds in asthma patients

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

Novartis announces EC approval of Cosentyx for treatment of ankylosing spondylitis, psoriatic arthritis

Health insurance coverage for transgender people is cost-effective, study finds

Fat cells produced from bone marrow may be linked to chronic diseases

Women with moderate-to-severe PMS at increased risk of developing high blood pressure in later life

First seasonal influenza vaccine containing adjuvant now approved by FDA

Breast Center of Acadiana to deploy Sectra Breast Imaging PACS in two freestanding imaging centers

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

New collaboration aims to develop novel generation artificial pancreas

Researchers reveal causal association between aneuploidy and cancer

xG Health Solutions introduces revolutionary care management platform

Molecular Dynamics to present revolutionary whole body CZT digital SPECT/CT solution at RSNA meeting

T1DM therapeutics market expected to reach $7.1 billion by 2021

Teledyne DALSA's CMOS X-Ray detector for mammography to be introduced at RSNA 2015 Technical Exhibition

Impax releases generic version of dutasteride capsules, 0.5 mg

Catasys to provide assistance to Humana members experiencing substance abuse challenges

Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News